TG Therapeutics, Inc. (BIT:1TGTX)
Italy flag Italy · Delayed Price · Currency is EUR
33.38
-0.32 (-0.95%)
At close: Jul 18, 2025

TG Therapeutics Revenue

TG Therapeutics had revenue of $120.86M USD in the quarter ending March 31, 2025, with 90.40% growth. This brings the company's revenue in the last twelve months to $386.39M, up 33.54% year-over-year. In the year 2024, TG Therapeutics had annual revenue of $329.00M with 40.80% growth.

Revenue (ttm)
$386.39M
Revenue Growth
+33.54%
P/S Ratio
13.07
Revenue / Employee
$1.14M
Employees
338
Market Cap
4.67B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024329.00M95.34M40.80%
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020152.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UniCredit24.79B
Intesa Sanpaolo25.43B
Enel SpA78.35B
Ferrari6.88B
Assicurazioni Generali55.30B
Eni S.p.A.90.96B
Leonardo S.p.a.18.26B
Poste Italiane13.78B
Revenue Rankings